Patents by Inventor Xiaofei YU

Xiaofei YU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BIOCOMPATIBLE SURFACE FOR QUANTUM SENSING AND METHODS THEREOF
    Publication number: 20240353400
    Abstract: The present disclosure relates to a device having various layers that are supported on a substrate having one or more color centers. Such layers can include one or more capture agents configured to capture a target. Methods of making and using such devices are also described herein.
    Type: Application
    Filed: July 15, 2022
    Publication date: October 24, 2024
    Inventors: Peter C. Maurer, Mouzhe Xie, Xiaofei Yu
  • DISPLAY SCREEN AND ELECTRONIC DEVICE
    Publication number: 20220328577
    Abstract: A display screen and an electronic device are provided. The display screen includes a metal anode layer, a semi-transparent cathode layer, and a pixel unit layer. The metal anode layer includes multiple metal anodes arranged at intervals. The semi-transparent cathode layer includes multiple semi-transparent cathodes. The pixel unit layer is sandwiched between the metal anode layer and the semi-transparent cathode layer. The pixel unit layer includes multiple pixel units arranged at intervals. Each pixel unit is located between a corresponding metal anode and a corresponding semi-transparent cathode. The display screen has a preset region, and in the preset region of the display screen, the semi-transparent cathode layer further includes a light-shielding portion and light-transmitting regions surrounded by the light-shielding portion. The light-shielding portion is connected with the multiple semi-transparent cathodes.
    Type: Application
    Filed: June 28, 2022
    Publication date: October 13, 2022
    Inventors: Zhijia CUI, Jingyang SUN, Xiaofei YU, Le YANG, Yuhu JIA
  • Immune modulator for immunotherapy and vaccine formulation
    Patent number: 10316072
    Abstract: A recombinant Flagrp170 protein and pharmaceutical compositions comprising a Flagrp170 protein and related molecules encoding same, and cells presenting such a protein are provided. The Flagrp170 protein comprises an NF-?B-activating domain of Flagellin and an ATP-binding domain truncated Grp170. The pharmaceutical compositions of the invention can be used for the treatment or prevention of cancer or infectious disease.
    Type: Grant
    Filed: October 26, 2017
    Date of Patent: June 11, 2019
    Assignees: VIRGINIA COMMONWEALTH UNIVERSITY, HEALTH RESEARCH, INC.
    Inventors: Xiang-Yang Wang, Xiaofei Yu, John R. Subjeck
  • IMMUNE MODULATOR FOR IMMUNOTHERAPY AND VACCINE FORMULATION
    Publication number: 20180105562
    Abstract: A recombinant Flagrp170 protein and pharmaceutical compositions comprising a Flagrp170 protein and related molecules encoding same, and cells presenting such a protein are provided. The Flagrp170 protein comprises an NF-?B-activating domain of Flagellin and an ATP-binding domain truncated Grp170. The pharmaceutical compositions of the invention can be used for the treatment or prevention of cancer or infectious disease.
    Type: Application
    Filed: October 26, 2017
    Publication date: April 19, 2018
    Applicants: VIRGINIA COMMONWEALTH UNIVERSITY, HEALTH RESEARCH, INC.
    Inventors: Xiang-Yang WANG, Xiaofei YU, John R. SUBJECK
  • Immune modulator for immunotherapy and vaccine formulation
    Patent number: 9822154
    Abstract: A recombinant Flagrp170 protein and pharmaceutical compositions comprising a Flagrp170 protein and related molecules encoding same, and cells presenting such a protein are provided. The Flagrp170 protein comprises an NF-KB-activating domain of Flagellin and an ATP-binding domain truncated Grp170. The pharmaceutical compositions of the invention can be used for the treatment or prevention of cancer or infectious disease.
    Type: Grant
    Filed: December 14, 2013
    Date of Patent: November 21, 2017
    Assignees: VIRGINIA COMMONWEALTH UNIVERSITY, HEALTH RESEARCH, INC.
    Inventors: Xiang-Yang Wang, Xiaofei Yu, John R. Subjeck
  • IMMUNE MODULATOR FOR IMMUNOTHERAPY AND VACCINE FORMULATION
    Publication number: 20150315255
    Abstract: A recombinant Flagrp170 protein and pharmaceutical compositions comprising a Flagrp170 protein and related molecules encoding same, and cells presenting such a protein are provided. The Flagrp170 protein comprises an NF-KB-activating domain of Flagellin and an ATP-binding domain truncated Grp170. The pharmaceutical compositions of the invention can be used for the treatment or prevention of cancer or infectious disease.
    Type: Application
    Filed: December 14, 2013
    Publication date: November 5, 2015
    Applicants: HEALTH RESEARCH, INC., VIRGINIA COMMONWEALTH UNIVERSITY
    Inventors: Xiang-Yang WANG, Xiaofei YU, John R. SUBJECK